DeutschNewstral
Article
bizjournals.com on 2021-07-20 22:30
Albireo gets FDA, European approval for pediatric liver disease drug
Related news
- Maryland biotech earns FDA approval for pediatric ADHD drugbizjournals.com
- Rockville biotech earns FDA approval for pediatric ADHD drugbizjournals.com
- MCelgene's rare disease drug gets FDA approvalmarketwatch.com
- FDA grants rare pediatric disease designation to RegenxBio gene therapybizjournals.com
Leadiant gets FDA approval for treatment for rare diseasethedailyrecord.com
FDA broadens approval for fish-oil derived heart disease drugnewatlas.com- Shire wins FDA approval for potential blockbuster rare disease drugbizjournals.com
- First therapy for childhood aging disease wins FDA approvalbizjournals.com
- Biogen scores FDA approval for generic eye disease biologicbizjournals.com
- SResearch Roundup: FDA approval for remdesivir, autism biomarker, immunotherapy for pediatric brain tumorsstanforddaily.com
- BIntercept Pharma Has a New Liver Drug. Don’t Expect FDA Approval to Lift the Stock, Analyst Says.barrons.com
- MAlnylam shares drop 1.8% on new FDA approval strategy for rare disease drugmarketwatch.com
- MSigns point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skepticsmarketwatch.com
South Side biotech gets FDA approval for drug to treat skin diseasepost-gazette.com- 23andMe gets FDA approval to use its genetic testing service — for one disease onlybizjournals.com
- A rare win: North Bay biotech gets FDA approval for drug to treat bone diseasebizjournals.com
- BArdelyx Skyrockets. Its Kidney Disease Drug Is a Step Closer to FDA Approval.4 min readbarrons.com
Reata stock soars on FDA approval for ultra-rare disease drug after 15 yearsDallas News- MImpax Labs stock surges 4.4% on FDA approval of generic kidney disease medication Renvelamarketwatch.com
First investigational drug to treat Alzheimer’s disease sent to FDA for approvalFOX 8 News Cleveland